GN Corporation obtained Japanese patent for Urethral Stricture Treatment by Hybrid Cell Therapy.
Treating male urethral stricture with the patient’s own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan. A longer duration of relief to patients who had recurrence of the disease after earlier conventional treatments, has been reported by this method called “Bees-Haus” (Buccal epithelium Expanded and Encapsulated in Scaffold‐Hybrid Approach to Urethral Stricture; https://onlinelibrary.wiley.com/doi/full/10.1111/iju.13852).
![尿道狭窄治療に関する特許](https://gncorporation.com/gnc/wp-content/uploads/2020/07/BEES-HAUS-500x375_2.gif)